The independent 340B TPA built for the
2026 landscape.
Aventi helps covered entities run smarter, more compliant 340B programs. Contract pharmacy and split billing on one modern platform, with transparent contingency-only pricing and a specialty and infusion focus.

What is Aventi?
The 340B program helps eligible providers stretch limited resources with discounted medications. Running it well is hard. Aventi is the partner that makes it simple. We help covered entities capture every dollar they are entitled to, stay compliant as the rules shift, and see their entire program in real time.
Covered entities across the US
Founder-owned 340B TPA
Pharmacies in our network

Contract Pharmacy
Run your contract pharmacy program from one place. Aventi captures eligible claims across a 10,000+ pharmacy network in real time, applies precise eligibility matching, and keeps every claim audit-ready. Capture referrals beyond your walls, work with a dedicated account manager, and never deal with end-of-month true-ups.
One platform.
Aventi runs split billing and contract pharmacy on a single foundational system, so you never juggle separate TPA tools again.
Split Billing
Built for hospitals with mixed-use areas or in-house pharmacies. Aventi automatically separates drug purchases by patient eligibility, splitting orders across 340B, GPO, and WAC accounts so you buy at the right price every time and stay compliant with the GPO Prohibition. Every purchase is digitally tied to an eligible dispense record in real time, so buyers trust their exact order quantities and true-ups disappear.
Built different from legacy TPAs.
The only TPA with a primary focus on specialty medications and infusion, closing the loop on the highest-value 340B opportunities.
Independent and founder-owned
No outside owners and no conflicting incentives. We answer to our clients, not to a parent company or a legacy platform. That independence shapes every decision we make.
Forward-thinking and tech-enabled
We build modern tooling for where 340B is heading, not where it has been. That means cleaner data, faster answers, and clarity on the changes coming to the program.
Flexible and adaptable
Every 340B program is different. We configure to how your team actually works instead of forcing you into a rigid system built for someone else.
Faster than the big players
We ship improvements and respond to your team in days, not quarters. When the rules change, you hear from us first.
Plugged into the 340B ecosystem.
Beacon-ready
Built for HRSA's rebate model pilot, ready when it resumes.
340B ESP
Real-time integration for contract-pharmacy restriction compliance.
Truzo (Kalderos)
API-connected as manufacturers migrate platforms.
Restriction-ready
Always current with the latest manufacturer restrictions and HRSA guidance, so your program stays compliant as the rules shift.
GFI tracking built in
Good Faith Inquiries submitted and tracked in one view, with status on every inquiry from pending to approved. Reconciliation will not disappear under the rebate model, and Aventi keeps you ahead of it.
Largest pharmacy network access.
Your patients fill prescriptions everywhere. Aventi's 10,000+ pharmacy network means eligible claims get captured wherever they happen.
Pharmacies and partners








Health systems and covered entities


Trusted by leaders in 340B.
Aventi Portal is the best Portal we have worked with from an ease and capability standpoint.
You guys are great. Your program runs smooth as silk.
The platform is more user friendly than anything I have used before, and financially transparent, which I like.
I like the post pickup inventory.
Don't miss the next one.
Our July webinar on MFP, Beacon, ESP and Truzo has wrapped. Join the list and we'll invite you to the next session.
Insights from the Aventi team.
What's New in 340B & Aventi Health: Q2 Update
A quarterly snapshot of the latest 340B news and Aventi updates.
Get our quarterly 340B update in your inbox.
Let's talk about your 340B program.
Tell us about your organization and we'll follow up to schedule a demo or assessment.